Evidence map›Paper›PMID 37571427›Full record

Trial reportNutrients2023

The Effect of the Rice Endosperm Protein Hydrolysate on the Subjective Negative Mood Status in Healthy Humans: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial.

Ryoko Nakayama, Daisuke Nishi, Masaru Sato, Akira Ito, Kimiko Uchiyama, Yuki Higuchi, Hajime Takahashi, Kousaku Ohinata

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryoko NakayamaRice Research Institute, Kameda Seika Co., Ltd., Niigata 950-0198, Niigata, Japan.
Daisuke NishiDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.ORCID 0000-0001-9349-3294
Masaru SatoDepartment of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusakamatari, Kisarazu 292-0818, Chiba, Japan.
Akira ItoRice Research Institute, Kameda Seika Co., Ltd., Niigata 950-0198, Niigata, Japan.
Kimiko UchiyamaRice Research Institute, Kameda Seika Co., Ltd., Niigata 950-0198, Niigata, Japan.
Yuki HiguchiRice Research Institute, Kameda Seika Co., Ltd., Niigata 950-0198, Niigata, Japan.ORCID 0000-0001-7757-9514
Hajime TakahashiRice Research Institute, Kameda Seika Co., Ltd., Niigata 950-0198, Niigata, Japan.
Kousaku OhinataDivision of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Uji 611-0011, Kyoto, Japan.ORCID 0000-0002-9944-8635

Funding

Japan Science and Technology Agency no. JPMJTR194A
6 · The paper itself

Abstract

The rice endosperm protein (REP) hydrolysate containing the following rice endosperm protein derived oligopeptides QQFLPEGQSQSQK, LPEGQSQSQK, and pEQFLPEGQSQSQK (a

Indexed as

OryzaProtein HydrolysatesAdultAffectAnimalsAnxietyDouble-Blind MethodEndospermHumansMiddle AgedYoung AdultProtein HydrolysatesEuthymia Scalefunctional foodmood statePOMS 2rice endosperm protein

Identifiers

PMID37571427
PMCPMC10421398

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.